| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 108.06B | 105.83B | 102.26B | 101.01B | 92.17B | 80.44B |
| Gross Profit | 15.58B | 14.35B | 15.05B | 17.79B | 18.64B | 11.42B |
| EBITDA | 6.07B | 4.00B | 7.32B | 10.04B | 12.62B | 426.00M |
| Net Income | -1.21B | -2.44B | -712.00M | 1.64B | 5.90B | -5.56B |
Balance Sheet | ||||||
| Total Assets | 131.18B | 136.50B | 144.67B | 138.09B | 135.04B | 127.81B |
| Cash, Cash Equivalents and Short-Term Investments | 22.08B | 20.40B | 26.34B | 25.15B | 29.61B | 26.65B |
| Total Debt | 38.02B | 40.28B | 38.90B | 37.53B | 39.88B | 38.55B |
| Total Liabilities | 65.31B | 70.35B | 73.75B | 75.55B | 77.81B | 78.39B |
| Stockholders Equity | 65.87B | 66.14B | 70.92B | 62.54B | 57.23B | 49.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.80B | -2.24B | -2.18B | -796.00M | -10.00B |
| Operating Cash Flow | 0.00 | -2.18B | 2.21B | 2.74B | 8.29B | -3.62B |
| Investing Cash Flow | 0.00 | -4.53B | -1.78B | -4.09B | -7.91B | -5.67B |
| Financing Cash Flow | 0.00 | -186.00M | -252.00M | -3.55B | 1.27B | 9.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥5.27T | 64.56 | ― | 1.41% | 13.61% | 17.01% | |
73 Outperform | ¥9.48T | 20.30 | 8.95% | 1.88% | 5.02% | 2.02% | |
67 Neutral | ¥40.73B | 12.31 | ― | 4.53% | 5.02% | 354.47% | |
67 Neutral | ¥158.27B | 11.45 | ― | 2.18% | -4.77% | -62.32% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥34.07B | 2.72 | ― | 1.95% | 7.89% | ― | |
51 Neutral | ¥65.38B | 9.09 | 2.26% | ― | 5.14% | 32.69% |